MEDICAL FACILITIES CORP (DR.CA) Fundamental Analysis & Valuation
TSX:DR • CA58457V5036
16.94 CAD
-0.02 (-0.12%)
Last: Mar 6, 2026, 07:00 PM
This DR.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
Overall DR gets a fundamental rating of 6 out of 10. We evaluated DR against 13 industry peers in the Health Care Providers & Services industry. DR has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. DR is cheap, but on the other hand it scores bad on growth. This makes DR very considerable for value investing!
1. DR.CA Profitability Analysis
1.1 Basic Checks
- In the past year DR was profitable.
- In the past year DR had a positive cash flow from operations.
- Of the past 5 years DR 4 years were profitable.
- Each year in the past 5 years DR had a positive operating cash flow.
1.2 Ratios
- DR's Return On Assets of 30.18% is amongst the best of the industry. DR outperforms 100.00% of its industry peers.
- With an excellent Return On Equity value of 94.43%, DR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- DR's Return On Invested Capital of 15.42% is amongst the best of the industry. DR outperforms 92.31% of its industry peers.
- DR had an Average Return On Invested Capital over the past 3 years of 16.37%. This is significantly above the industry average of 7.67%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.18% | ||
| ROE | 94.43% | ||
| ROIC | 15.42% |
ROA(3y)8.42%
ROA(5y)6.13%
ROE(3y)25.39%
ROE(5y)18.93%
ROIC(3y)16.37%
ROIC(5y)14.6%
1.3 Margins
- DR's Profit Margin of 31.60% is amongst the best of the industry. DR outperforms 100.00% of its industry peers.
- DR's Profit Margin has improved in the last couple of years.
- DR's Operating Margin of 15.59% is amongst the best of the industry. DR outperforms 100.00% of its industry peers.
- In the last couple of years the Operating Margin of DR has remained more or less at the same level.
- DR has a better Gross Margin (63.75%) than 92.31% of its industry peers.
- In the last couple of years the Gross Margin of DR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.59% | ||
| PM (TTM) | 31.6% | ||
| GM | 63.75% |
OM growth 3Y-0.97%
OM growth 5Y-1.3%
PM growth 3Y78.64%
PM growth 5Y55.2%
GM growth 3Y-0.53%
GM growth 5Y-0.42%
2. DR.CA Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DR is creating value.
- DR has less shares outstanding than it did 1 year ago.
- DR has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, DR has an improved debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 1.41, we must say that DR is in the distress zone and has some risk of bankruptcy.
- DR has a Altman-Z score of 1.41. This is in the better half of the industry: DR outperforms 61.54% of its industry peers.
- DR has a debt to FCF ratio of 2.05. This is a good value and a sign of high solvency as DR would need 2.05 years to pay back of all of its debts.
- DR has a better Debt to FCF ratio (2.05) than 92.31% of its industry peers.
- DR has a Debt/Equity ratio of 1.02. This is a high value indicating a heavy dependency on external financing.
- DR's Debt to Equity ratio of 1.02 is in line compared to the rest of the industry. DR outperforms 53.85% of its industry peers.
- Even though the debt/equity ratio score it not favorable for DR, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.02 | ||
| Debt/FCF | 2.05 | ||
| Altman-Z | 1.41 |
ROIC/WACC1.91
WACC8.09%
2.3 Liquidity
- A Current Ratio of 1.79 indicates that DR should not have too much problems paying its short term obligations.
- Looking at the Current ratio, with a value of 1.79, DR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- DR has a Quick Ratio of 1.67. This is a normal value and indicates that DR is financially healthy and should not expect problems in meeting its short term obligations.
- With an excellent Quick ratio value of 1.67, DR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.67 |
3. DR.CA Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 60.81% over the past year.
- Looking at the last year, DR shows a very negative growth in Revenue. The Revenue has decreased by -41.68% in the last year.
- The Revenue has been decreasing by -3.59% on average over the past years.
EPS 1Y (TTM)60.81%
EPS 3Y10.86%
EPS 5Y0%
EPS Q2Q%-23.33%
Revenue 1Y (TTM)-41.68%
Revenue growth 3Y-5.96%
Revenue growth 5Y-3.59%
Sales Q2Q%-20.29%
3.2 Future
- The Earnings Per Share is expected to grow by 6.63% on average over the next years.
- DR is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -12.02% yearly.
EPS Next Y24.91%
EPS Next 2Y15.15%
EPS Next 3Y10.76%
EPS Next 5Y6.63%
Revenue Next Year-20.97%
Revenue Next 2Y-10.81%
Revenue Next 3Y-15.97%
Revenue Next 5Y-12.02%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. DR.CA Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 10.46 indicates a reasonable valuation of DR.
- DR's Price/Earnings ratio is rather cheap when compared to the industry. DR is cheaper than 92.31% of the companies in the same industry.
- When comparing the Price/Earnings ratio of DR to the average of the S&P500 Index (26.29), we can say DR is valued rather cheaply.
- With a Price/Forward Earnings ratio of 9.98, the valuation of DR can be described as very reasonable.
- Based on the Price/Forward Earnings ratio, DR is valued cheaply inside the industry as 92.31% of the companies are valued more expensively.
- DR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.57.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.46 | ||
| Fwd PE | 9.98 |
4.2 Price Multiples
- DR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DR is cheaper than 100.00% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, DR is valued cheaper than 84.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.52 | ||
| EV/EBITDA | 4.81 |
4.3 Compensation for Growth
- DR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The excellent profitability rating of DR may justify a higher PE ratio.
PEG (NY)0.42
PEG (5Y)N/A
EPS Next 2Y15.15%
EPS Next 3Y10.76%
5. DR.CA Dividend Analysis
5.1 Amount
- DR has a Yearly Dividend Yield of 2.14%. Purely for dividend investing, there may be better candidates out there.
- DR's Dividend Yield is a higher than the industry average which is at 1.39.
- DR's Dividend Yield is comparable with the S&P500 average which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.14% |
5.2 History
- The dividend of DR decreases each year by -19.91%.
- DR has been paying a dividend for at least 10 years, so it has a reliable track record.
- DR has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-19.91%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
- 6.72% of the earnings are spent on dividend by DR. This is a low number and sustainable payout ratio.
DP6.72%
EPS Next 2Y15.15%
EPS Next 3Y10.76%
DR.CA Fundamentals: All Metrics, Ratios and Statistics
TSX:DR (3/6/2026, 7:00:00 PM)
16.94
-0.02 (-0.12%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)03-12 2026-03-12
Inst Owners11.96%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap300.85M
Revenue(TTM)257.36M
Net Income(TTM)81.33M
Analysts40
Price Target16.58 (-2.13%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.14% |
Yearly Dividend0.35
Dividend Growth(5Y)-19.91%
DP6.72%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.6%
Min EPS beat(2)-7.54%
Max EPS beat(2)6.33%
EPS beat(4)2
Avg EPS beat(4)3.38%
Min EPS beat(4)-24.98%
Max EPS beat(4)39.71%
EPS beat(8)3
Avg EPS beat(8)-25.78%
EPS beat(12)5
Avg EPS beat(12)32.86%
EPS beat(16)7
Avg EPS beat(16)-103.27%
Revenue beat(2)1
Avg Revenue beat(2)-1.3%
Min Revenue beat(2)-4.5%
Max Revenue beat(2)1.91%
Revenue beat(4)1
Avg Revenue beat(4)-6.39%
Min Revenue beat(4)-18.84%
Max Revenue beat(4)1.91%
Revenue beat(8)3
Avg Revenue beat(8)-3.49%
Revenue beat(12)4
Avg Revenue beat(12)-2.43%
Revenue beat(16)5
Avg Revenue beat(16)-2.23%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-5.41%
EPS NQ rev (3m)-5.41%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.79%
Revenue NQ rev (1m)-1.53%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)1.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.46 | ||
| Fwd PE | 9.98 | ||
| P/S | 0.86 | ||
| P/FCF | 4.52 | ||
| P/OCF | 4.16 | ||
| P/B | 2.56 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.81 |
EPS(TTM)1.62
EY9.56%
EPS(NY)1.7
Fwd EY10.02%
FCF(TTM)3.75
FCFY22.13%
OCF(TTM)4.07
OCFY24.05%
SpS19.74
BVpS6.61
TBVpS-0.87
PEG (NY)0.42
PEG (5Y)N/A
Graham Number15.52
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.18% | ||
| ROE | 94.43% | ||
| ROCE | 18.66% | ||
| ROIC | 15.42% | ||
| ROICexc | 19.71% | ||
| ROICexgc | 46.81% | ||
| OM | 15.59% | ||
| PM (TTM) | 31.6% | ||
| GM | 63.75% | ||
| FCFM | 18.99% |
ROA(3y)8.42%
ROA(5y)6.13%
ROE(3y)25.39%
ROE(5y)18.93%
ROIC(3y)16.37%
ROIC(5y)14.6%
ROICexc(3y)21.7%
ROICexc(5y)18.79%
ROICexgc(3y)53.59%
ROICexgc(5y)43.79%
ROCE(3y)19.81%
ROCE(5y)17.76%
ROICexgc growth 3Y35.06%
ROICexgc growth 5Y23.36%
ROICexc growth 3Y18.42%
ROICexc growth 5Y13.1%
OM growth 3Y-0.97%
OM growth 5Y-1.3%
PM growth 3Y78.64%
PM growth 5Y55.2%
GM growth 3Y-0.53%
GM growth 5Y-0.42%
F-Score6
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.02 | ||
| Debt/FCF | 2.05 | ||
| Debt/EBITDA | 1.54 | ||
| Cap/Depr | 25.03% | ||
| Cap/Sales | 1.64% | ||
| Interest Coverage | 7.65 | ||
| Cash Conversion | 93.1% | ||
| Profit Quality | 60.09% | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z | 1.41 |
F-Score6
WACC8.09%
ROIC/WACC1.91
Cap/Depr(3y)47.79%
Cap/Depr(5y)40.36%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.81%
EPS 3Y10.86%
EPS 5Y0%
EPS Q2Q%-23.33%
EPS Next Y24.91%
EPS Next 2Y15.15%
EPS Next 3Y10.76%
EPS Next 5Y6.63%
Revenue 1Y (TTM)-41.68%
Revenue growth 3Y-5.96%
Revenue growth 5Y-3.59%
Sales Q2Q%-20.29%
Revenue Next Year-20.97%
Revenue Next 2Y-10.81%
Revenue Next 3Y-15.97%
Revenue Next 5Y-12.02%
EBIT growth 1Y-46.1%
EBIT growth 3Y-6.86%
EBIT growth 5Y-4.85%
EBIT Next Year1.16%
EBIT Next 3Y-5.64%
EBIT Next 5Y-5.23%
FCF growth 1Y-6.31%
FCF growth 3Y4.28%
FCF growth 5Y3.38%
OCF growth 1Y-24.65%
OCF growth 3Y3.26%
OCF growth 5Y1.55%
MEDICAL FACILITIES CORP / DR.CA FAQ
What is the fundamental rating for DR stock?
ChartMill assigns a fundamental rating of 6 / 10 to DR.CA.
Can you provide the valuation status for MEDICAL FACILITIES CORP?
ChartMill assigns a valuation rating of 9 / 10 to MEDICAL FACILITIES CORP (DR.CA). This can be considered as Undervalued.
Can you provide the profitability details for MEDICAL FACILITIES CORP?
MEDICAL FACILITIES CORP (DR.CA) has a profitability rating of 8 / 10.
What is the expected EPS growth for MEDICAL FACILITIES CORP (DR.CA) stock?
The Earnings per Share (EPS) of MEDICAL FACILITIES CORP (DR.CA) is expected to grow by 24.91% in the next year.
How sustainable is the dividend of MEDICAL FACILITIES CORP (DR.CA) stock?
The dividend rating of MEDICAL FACILITIES CORP (DR.CA) is 5 / 10 and the dividend payout ratio is 6.72%.